A rating of 50 puts cbdMD Inc (YCBD) near the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. cbdMD Inc's score of 50 means it scores higher than 50% of stocks in the industry. cbdMD Inc also received an overall rating of 24, putting it above 24% of all stocks. Drug Manufacturers - Specialty & Generic is ranked 139 out of the 148 industries.
What do These Ratings Mean?
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 24 means the stock is more attractive than 24 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With cbdMD Inc Stock Today?
cbdMD Inc (YCBD) stock is up 5.42% while the S&P 500 has fallen -0.21% as of 11:41 AM on Wednesday, Dec 2. YCBD is up $0.15 from the previous closing price of $2.77 on volume of 223,691 shares. Over the past year the S&P 500 is higher by 18.16% while YCBD has fallen -3.63%. YCBD earned $1.07 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 2.72.